4.3 Article

Cannabidiol-2′,6′-dimethyl Ether as an Effective Protector of 15-Lipoxygenase-Mediated Low-Density Lipoprotein Oxidation in Vitro

Related references

Note: Only part of the references are listed.
Article Chemistry, Medicinal

Δ9-Tetrahydrocannabinol and Its Major Metabolite Δ9-Tetrahydrocannabinol-11-oic Acid as 15-Lipoxygenase Inhibitors

Shuso Takeda et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2011)

Review Biochemistry & Molecular Biology

Molecular enzymology of lipoxygenases

Igor Ivanov et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)

Review Pharmacology & Pharmacy

Modulation of UDP-glucuronosyltransferase activity by protein-protein association

Yuji Ishii et al.

DRUG METABOLISM REVIEWS (2010)

Article Cardiac & Cardiovascular Systems

Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis

Yasushi Ishigaki et al.

CIRCULATION (2008)

Article Pharmacology & Pharmacy

6-Azidohex-2-yne-cannabidiol:: a potential neutral, competitive cannabinoid CB1 receptor antagonist

A Thomas et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2004)

Article Hematology

Hypoxia increases LDL oxidation and expression of 15-lipoxygenase-2 in human macrophages

EK Rydberg et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)

Review Pharmacology & Pharmacy

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

AC Howlett et al.

PHARMACOLOGICAL REVIEWS (2002)

Article Biochemistry & Molecular Biology

Oleyl sulfate reveals allosteric inhibition of soybean lipoxygenase-1 and human 15-lipoxygenase

R Mogul et al.

BIOCHEMISTRY (2000)